Glibenclamide API

Glibenclamide (also known as Glyburide) is an oral antidiabetic agent belonging to the sulfonylurea class, used primarily in the treatment of type 2 diabetes mellitus. It works by stimulating the release of insulin from pancreatic β-cells, thereby helping to lower blood glucose levels.

Glibenclamide is commonly formulated into tablets and used either alone or in combination with other antidiabetic agents. The API is manufactured under cGMP-compliant conditions to meet global pharmacopoeial standards (USP/EP/BP/IP), offering excellent stability, high purity, and consistent quality for formulation development.